Agilis Robotics Completes New Round of Live Animal Trials with Miniaturized Robotic Instruments for Endoscopic Surgery

Agilis Robotics^TM (Agilis), a leading developer of flexible robotic instruments that support endoscopic surgery through natural orifices of the body (e.g. along the gastrointestinal tract and in the bladder), has recently completed the second round of live animal testing using its proprietary robot. Dr. Jason Y.K. Chan, the co-founder of Agilis Robotics^TM , conducted the test with the firm’s second-generation device on a live pig specimen and successfully removed artificial tumors using the en-bloc resection of bladder tumor (ERBT) technique. The test results met expectations, demonstrating promising results for the accuracy, safety, and efficacy of the firm’s medical robotic system.

Drawing on the advice of surgeons in earlier experiments, the research team has made several technical improvements to the original system that increased the efficiency of the surgery.

Recommended AI: The Transformational Impact of Low-code on the SaaS Industry in 2023

The 2^nd generation prototype system has been optimized for more streamlined surgical control

The Agilis Robotics^TM system is a surgical robotic solution designed for endoscopic surgery. The system features a set of flexible surgical robotic instruments, a positioning cart and a surgeon’s control chair. The flexible robotic instruments, with a diameter of less than 2.8 mm, can grip and cut away tumor tissue to remove it in its entirety.

The second-generation prototype system used in this test includes several improvements over the original system. With a smaller footprint, the updated positioning cart is 50% smaller, making it highly compact and easily positioned in the operating room.

Second, the newly developed endoscope holder offers the surgeon great flexibility for positioning the endoscope and robotic instruments. During operation, the surgeon can move the endoscope with ease using just one hand in thanks to the holder’s sensor. The holder includes an automatic locking mechanism that prevents the unit from moving around freely, streamlining the surgeon’s work and improving the procedure’s safety.

The surgical tools have also been improved in this prototype iteration, allowing the surgeon to visualize the surgical field beyond the instruments more clearly and increase its load capacity to meet more demanding requirements. The electrosurgical knife instrument was also improved to enable bipolar diathermy, which substantially enhances tissue cutting effectiveness in bladder tumor resection. The most notable improvements are made to the controls and mechanical transmission in terms of precision and reduced control latency. This gives the surgeon a more intuitive and responsive control experience compared with manual operation. In addition to the controls, the team has also made substantial improvements to the system’s ergonomic design and training simulator.

Recommended AI: SaaS Maker 3 Paves Way for New Era of Software Innovation

Next, the company will test the system in animals for upper and lower gastrointestinal (GI) endoscopic submucosal dissection (ESD). This will be a major milestone for the company, demonstrating their potential within the sizeable market for GI diseases.

Agilis Robotics^TM invited prominent gastroenterology and hepatology specialist Dr. Peter Chan Chun Wing to evaluate the system before its entry into the digestive tract market. Dr. Chan has almost 20 years of medical specialty practice, focusing on endoscopy and GI surgery. Dr. Chan is listed as a colonoscopy provider to the Colorectal Cancer Screening Programme of the Hong Kong Department of Health, offering pre-screening advice and colonoscopies for eligible individuals.

As the first internal medicine physician to use the system, Dr. Chan not only carried out ev-vivo tissue resection tests but also offered guidance on the system’s potential for the GI market. He foresees the system’s accessibility in general endoscopy clinics and centers, which is crucial to making the system widely adopted throughout healthcare institutions.

Recommended AI: aelf Announces the form of aelf DAO, Enhancing Decentralization of Governance and Ecosystem Growth

[To share your insights with us, please write to sghosh@martechseries.com]

The post Agilis Robotics Completes New Round of Live Animal Trials with Miniaturized Robotic Instruments for Endoscopic Surgery appeared first on AiThority.

instrument
healthcare
medicine
health
medical
device
ai
software
research
department of health